Rotational thromboelastometry (ROTEM®) allows guided blood product resuscitation to correct trauma-induced coagulopathy in bleeding trauma patients. FIBTEM amplitude at 10 min (A10) has been widely used to identify hypofibrinogenaemia; locally a threshold of < 11 mm has guided fibrinogen replacement. Amplitude at 5 min (A5) carries an inherent time advantage. The primary aim was to explore the relationship between FIBTEM A5 and A10 in a trauma. Secondary aim was to investigate the use of A5 as a surrogate for A10 within a fibrinogen-replacement algorithm.
Retrospective observational cohort study of arrival ROTEM results from 1539 consecutive trauma patients at a Level 1 trauma centre in Australia. Consistency of agreement between FIBTEM A5 and A10 was assessed. A new fibrinogen replacement threshold was developed for A5 using the A5–A10 bias; this was clinically compared to the existing A10 threshold.
FIBTEM A5 displayed excellent consistency of agreement with A10. Intraclass correlation coefficient = 0.972 (95% confidence interval [CI] 0.969–0.974). Bias of A5 to A10 was − 1.49 (95% CI 1.43–1.56) mm. 19.34% patients met the original local threshold of A10 < 11 mm; 19.28% patients met the new, bias-adjusted threshold of A5 < 10 mm.
ROTEM FIBTEM A5 reliably predicts A10 in trauma. This further validates use of the A5 result over A10 allowing faster decision-making in time-critical resuscitation of trauma patients. A modification of -1 to the A10 threshold might be appropriate for use with the A5 value in trauma patients.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.
Amplitude at five minutes
Amplitude at ten minutes
Maximum clot firmness
Damage control resuscitation
Injury severity score
Packed red cells
International normalised ratio
Roth GA, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1736–88.
Søreide K, Krüger AJ, Vårdal AL, Ellingsen CL, Søreide E, Lossius HM. Epidemiology and contemporary patterns of trauma deaths: changing place, similar pace. Older Face World J Surg. 2007;31:2092–103.
Cole E, Weaver A, Gall L, West A, Nevin D, Tallach R, et al. A decade of damage control resuscitation: new transfusion practice, new survivors, new directions. Ann Surg. 2021;273(6):1215–20.
Winearls J, Mitra B, Reade MC. Haemotherapy algorithm for the management of trauma-induced coagulopathy: an Australian perspective. Curr Opin Anesthesiol. 2017;30:265–76.
Whiting D, DiNardo JA. TEG and ROTEM: technology and clinical applications. Am J Hematol. 2014;89:228–32.
Rourke C, Curry N, Khan S, Taylor R, Raza I, Davenport R, et al. Fibrinogen levels during trauma hemorrhage, response to replacement therapy, and association with patient outcomes. J Thromb Haemost. 2012;10:1342–51.
Hagemo JS, Christiaans SC, Stanworth SJ, Brohi K, Johansson PI, Goslings JC, et al. Detection of acute traumatic coagulopathy and massive transfusion requirements by means of rotational thromboelastometry: an international prospective validation study. Crit Care. 2015;19:97.
Tapia NM, Chang A, Norman M, Welsh F, Scott B, Wall MJ, et al. TEG-guided resuscitation is superior to standardized MTP resuscitation in massively transfused penetrating trauma patients. J Trauma Acute Care Surg. 2013;74:378–85 (Discussion 385-386).
Gonzalez E, Moore EE, Moore HB, Chapman MP, Chin TL, Ghasabyan A, et al. Goal-directed hemostatic resuscitation of trauma-induced coagulopathy. Ann Surg. 2016;263:1051–9.
Baksaas-Aasen K, Gall LS, Stensballe J, Juffermans NP, Curry N, Maegele M, et al. Viscoelastic haemostatic assay augmented protocols for major trauma haemorrhage (ITACTIC): a randomized, controlled trial. Intensive Care Med. 2021;47:49–59.
Spahn DR, Bouillon B, Cerny V, Duranteau J, Filipescu D, Hunt BJ, et al. The European guideline on management of major bleeding and coagulopathy following trauma : fifth edition. Crit Care. 2019;23:98.
Baksaas-Aasen K, Dieren SV, Balvers K, Juffermans N, Næss P, Rourke C, et al. Data-driven development of ROTEM and TEG algorithms for the management of trauma hemorrhage: a prospective observational multicenter study. Ann Surg. 2019;270:1178–85.
Görlinger K, Dirkmann D, Solomon C, Hanke AA. Fast interpretation of thromboelastometry in non-cardiac surgery: reliability in patients with hypo-, normo-, and hypercoagulability. BJA Br J Anaesth. 2013;110:222–30 (Oxford Academic).
Dirkmann D, Görlinger K, Dusse F, Kottenberg E, Peters J. Early thromboelastometric variables reliably predict maximum clot firmness in patients undergoing cardiac surgery: a step towards earlier decision making. Acta Anaesthesiol Scand. 2013;57:594–603.
Olde Engberink RHG, Kuiper GJAJM, Wetzels RJH, Nelemans PJ, Lance MD, Beckers EAM, et al. Rapid and correct prediction of thrombocytopenia and hypofibrinogenemia with rotational thromboelastometry in cardiac surgery. J Cardiothorac Vasc Anesth. 2014;28:210–6.
Kelly JM, Rizoli S, Veigas P, Hollands S, Min A. Using rotational thromboelastometry clot firmness at 5 minutes (ROTEM® EXTEM A5) to predict massive transfusion and in-hospital mortality in trauma: a retrospective analysis of 1146 patients. Anaesthesia. 2018;73:1103–9.
von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. PLOS Med. 2007;4:e296 (Public Library of Science).
Palmer CS, Gabbe BJ, Cameron PA. Defining major trauma using the 2008 Abbreviated Injury Scale. Injury. 2016;47:109–15.
Portney LG, Watkins MP. Foundations of clinical research: applications to practice. Third. Upper Saddle River. Pearson: Prentice Hall; 2000.
Seebold JA, Campbell D, Wake E, Walters K, Ho D, Chan E, et al. Targeted fibrinogen concentrate use in severe traumatic haemorrhage. Crit Care Resusc. 2019;21:171 (The Australasian Medical Publishing Company).
Ho D, Chan E, Campbell D, Wake E, Walters K, Bulmer AC, et al. Targeted cryoprecipitate transfusion in severe traumatic haemorrhage. Injury [Internet]. 2020 [cited 2020 Jul 1]; Available from: http://www.sciencedirect.com/science/article/pii/S0020138320304721
Martin Bland J, Altman Douglas G. Statistical methods for assessing agreement between two methods of clinical measurement. The lancet. 1986;327:307–10.
Meyer ASP, Meyer MAS, Sørensen AM, Rasmussen LS, Hansen MB, Holcomb JB, et al. Thrombelastography and rotational thromboelastometry early amplitudes in 182 trauma patients with clinical suspicion of severe injury. J Trauma Acute Care Surg. 2014;76:682–90.
McGraw KO, Wong SP. Forming inferences about some intraclass correlation coefficients. Psychol Methods US Am Psychol Assoc. 1996;1:30–46.
Schuck P. Assessing reproducibility for interval data in health-related quality of life questionnaires: Which coefficient should be used? Qual Life Res. 2004;13:571–85.
Wikkelsø A, Lunde J, Johansen M, Stensballe J, Wetterslev J, Møller AM, et al. Fibrinogen concentrate in bleeding patients. Cochrane Database Syst Rev [Internet]. John Wiley & Sons, Ltd; 2013 [cited 2020 Jun 15]; Available from: https://www.cochranelibrary.com/cdsr/doi/https://doi.org/10.1002/14651858.CD008864.pub2/abstract
Jensen NHL, Stensballe J, Afshari A. Comparing efficacy and safety of fibrinogen concentrate to cryoprecipitate in bleeding patients: a systematic review. Acta Anaesthesiol Scand. 2016;60:1033–42.
Curry N, Rourke C, Davenport R, Stanworth S, Brohi K. Fibrinogen replacement in trauma haemorrhage. Scand J Trauma Resusc Emerg Med. 2014;22:A5.
Dr Ian Hughes: Office for Research Governance and Development, Gold Coast Health.
The authors declare no external funding sources.
Conflict of interest
The authors (Alexander Blayney, James P.A. McCullough, Elizabeth Wake, Kerin Walters, Don Campbell, Debbie Ho, Erick Chan, Aashish Chalasani and James Winearls) declare that they have no conflict of interest.
This study was performed according to the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. Ethics approval was obtained from the Gold Coast Hospital and Health Service Human Research Ethics Committee on the 26th March 2014 (HREC/14/QGC/17).
Waived consent was granted as section 2.3 of the National Statement on Ethical Conduct in Human Research.
Below is the link to the electronic supplementary material.
Supplementary Additional File 1 PDF of the local current ROTEM transfusion algorithm for critical bleeding. See “Step 2” (interpretation of FIBTEM for fibrinogen replacement). It should be noted that the exact wording of the algorithm differs slightly to that used in the report: The algorithm uses ≤ 10 mm as a threshold; this is expressed as < 11 mm in the report to facilitate direct comparison to the literature. As the outputs from the ROTEM are expressed as integers, the interpretation of these two thresholds is identical (PDF 375 KB)
Supplementary Additional File 2 PDF of the Trauma criteria used to define patients for our cohort. The local service operates a two tier trauma activation protocol: “Alert” and “Respond”. For the purposes of this study, patients meeting criteria for either tier were included in our trauma cohort (PDF 183 KB)
About this article
Cite this article
Blayney, A., McCullough, J., Wake, E. et al. Substitution of ROTEM FIBTEM A5 for A10 in trauma: an observational study building a case for more rapid analysis of coagulopathy. Eur J Trauma Emerg Surg (2021). https://doi.org/10.1007/s00068-021-01652-w
- Rotational thromboelastometry